HGH FRAGMENT 176-191 5mg
(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY)
HGH Frag 176-191 5mg
is a synthetic peptide representing the terminal end of the human growth hormone molecule. It is specifically designed to isolate the fat-burning (lipolytic)properties of growth hormone without affecting blood sugar or causing bone and organ growth.
Core Function and Mechanism
While full-spectrum HGH (191aa) has both anabolic (muscle building) and lipolytic (fat burning) effects, the "Fragment" targets only the fat metabolism pathway.
- Lipolysis: It stimulates the breakdown of fat, particularly in stubborn adipose tissue.
- Inhibition of Lipogenesis: Research suggests it helps prevent the formation of new fatty acids and other lipids.
- Metabolic Safety: Unlike full HGH, HGH Frag 176-191 does not compete for the GH receptor, meaning it does not decrease insulin sensitivity or cause glucose intolerance.
Potential Benefits (Research)
Studies, primarily in animal models and specialized research settings, have highlighted:
- Targeted Fat Loss: Potentially 12.5 times stronger than regular HGH for fat burning.
- Weight Management: Significant reductions in body weight and fat mass in obese subjects without changing food intake.
- No "GH Side Effects": It does not cause the joint pain, water retention (oedema), or carpal tunnel syndrome often associated with high-dose HGH.
Administration and Half-Life
- Method: Administered via subcutaneous injection, usually into the abdominal fat.
- Timing: Most effective when taken on an empty stomach(fasted), as insulin can blunt its lipolytic effects.
- Half-Life: It has a very short half-life of approximately 20–30 minutes, requiring precise timing around activity or fasting for maximum efficacy.
Safety and Regulatory Status
- FDA Status: HGH Frag 176-191 is not FDA-approved for human medical use. The FDA has categorized it as a substance with significant safety concerns, making it ineligible for traditional compounding.
- WADA Status: It is strictly prohibited in professional sports under the WADA Prohibited List (S2 category).
- Side Effects: Generally reported as mild, including redness or soreness at the injection site, occasional lethargy, or temporary headaches.
Warning: HGH Frag 176-191 is legally sold only as a "research chemical" for laboratory use. Always consult a medical professional before considering any form of peptide therapy.